8-K: Schrödinger Appoints Richie Jain as CFO, Geoffrey Porges Departs

Schrödinger, Inc. announces the appointment of Richie Jain as its new Executive Vice President and Chief Financial Officer, effective May 16, 2025, succeeding Geoffrey Porges who will remain as an advisor through June 6, 2025.

Summary

• Schrödinger, Inc. has appointed Richie Jain as Executive Vice President and Chief Financial Officer, effective May 16, 2025.
• Richie Jain previously served as the company's Senior Vice President, Strategic Finance and Head of Corporate and Business Development since February 2024.
• Prior to joining Schrödinger, Mr. Jain worked at Morgan Stanley & Co. LLC for over 13 years, most recently as a Managing Director in healthcare investment banking and mergers and acquisitions.
• Mr. Jain's employment agreement includes an annual base salary of $535,000.
• He is eligible for a target bonus of up to 55% of his annualized base salary for 2025, prorated for the period beginning on the Effective Date and ending on December 31, 2025.
• The company expects to grant Mr. Jain a nonstatutory stock option to purchase up to 18,750 shares of common stock and restricted stock units with respect to 9,375 shares of common stock.
• Geoffrey Porges, the former CFO, has mutually agreed to separate from the role, effective May 16, 2025, and will remain as an advisor through June 6, 2025.
• Mr. Jain will be entitled to participate in the Company's Amended and Restated Executive Severance and Change in Control Benefits Plan, as amended (the Executive Severance Plan).

Sentiment

Score: 7

Explanation: The announcement is generally positive, highlighting a smooth transition in financial leadership with a qualified new CFO. The lack of negative details surrounding the previous CFO's departure contributes to a neutral to slightly positive sentiment.

Positives

• The appointment of Richie Jain brings a seasoned financial executive with experience in strategic finance, corporate development, and investment banking to Schrödinger.
• Mr. Jain's prior experience at Morgan Stanley in healthcare investment banking and M&A could be valuable for Schrödinger's strategic initiatives.
• The employment agreement includes standard compensation and benefits packages, including a competitive base salary, bonus potential, equity awards, and severance benefits.

Negatives

• The departure of Geoffrey Porges as CFO could create a temporary disruption in the company's financial leadership.
• The company will incur costs associated with the transition and onboarding of the new CFO.
• The document does not provide specific reasons for Geoffrey Porges' departure, which could raise questions among investors.

Risks

• The transition to a new CFO could pose operational risks if not managed effectively.
• Uncertainty surrounding the reasons for the previous CFO's departure could negatively impact investor sentiment.
• The company's performance targets for the new CFO's bonus eligibility could be challenging to achieve.

Future Outlook

The company expects to grant Mr. Jain a nonstatutory stock option and restricted stock units, subject to continued service.

Management Comments

• The document does not contain direct quotes from management, but it implies confidence in Richie Jain's ability to fulfill the CFO role.

Industry Context

The appointment of a new CFO is a common occurrence in the corporate world, and the selection of Richie Jain, with his background in healthcare investment banking, suggests a focus on strategic financial management and potential M&A activities.

Comparison to Industry Standards

• A base salary of $535,000 for a CFO position at a company like Schrödinger is within the typical range for similar roles in the biotech and pharmaceutical industries.
• Equity grants, including stock options and restricted stock units, are standard components of executive compensation packages in publicly traded companies to align management's interests with those of shareholders.
• Companies like Relay Therapeutics, Recursion Pharmaceuticals, and Exscientia, which are also involved in computational drug discovery, may offer comparable compensation packages to their CFOs.

Management Changes

Stakeholder Impact

• Shareholders may view the appointment of a new CFO as a significant event that could impact the company's financial performance and strategic direction.
• Employees in the finance department will be directly affected by the change in leadership.
• Customers and partners may experience minimal impact from this transition.

Next Steps

• Richie Jain will assume his responsibilities as CFO, focusing on strategic financial management and corporate development.
• Geoffrey Porges will continue to serve as an advisor to ensure a smooth transition.
• The company will grant Mr. Jain the expected stock options and restricted stock units.

Key Dates

Keywords

CFO, Richie Jain, Geoffrey Porges, Schrödinger, Appointment, Executive, Finance, Compensation, Stock Options, Resignation